DTE
50
3
DG
2
-6
ACN
47
-2
FDX
36
-4
IP
70
2
VRTX
46
2
BA
52
2
SWK
56
-2
HUM
48
6
SYK
64
-4
AMP
69
-3
EQR
54
-2
SYF
85
2
ILMN
32
-3
LB
34
8
PX
75
5
PPL
54
2
DHR
35
3
AMAT
36
5
LLY
39
9
DTE
50
3
DG
2
-6
ACN
47
-2
FDX
36
-4
IP
70
2
VRTX
46
2
BA
52
2
SWK
56
-2
HUM
48
6
SYK
64
-4
AMP
69
-3
EQR
54
-2
SYF
85
2
ILMN
32
-3
LB
34
8
PX
75
5
PPL
54
2
DHR
35
3
AMAT
36
5
LLY
39
9
Financhill
Back

Rhythm Pharmaceuticals 10K Form

Buy
79

RYTM
Rhythm Pharmaceuticals

Last Price:
59.40
Seasonality Move:
6.59%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RYTM News And Ratings

See the #1 stock for the next 7 days that we like better than RYTM

RYTM Financial Statistics

Sales & Book Value

Annual Sales: $77.43M
Cash Flow: $14.79M
Price / Cash Flow: 0
Annual Sales: $0.18
Price / Book: 320.57

Profitability

EPS (TTM): -4.33000
Net Income (TTM): $-258.91M
Gross Margin: $68.13M
Return on Equity: -208.96%
Return on Assets: -76.55%

Rhythm Pharmaceuticals Earnings Forecast

Key Rhythm Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 6 years for RYTM is 87.99%.
  • The Selling, General & Administrative Expenses for RYTM have been equal to 151.80% of Gross Profit Margin.
  • The Research & Development expenses have been 174.29% of Revenue.
  • The Interest Expense is -7.52% of Operating Income.
  • The Net Earning history of RYTM is -238.52% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 4 years.

Rhythm Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: RYTM
CUSIP: 76243J
Website: rhythmtx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.49
Quick Ratio: 3.25

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RYTM Technical Analysis vs Fundamental Analysis

Buy
79
Rhythm Pharmaceuticals (RYTM) is a Buy

Is Rhythm Pharmaceuticals a Buy or a Sell?